EffRx Overview
- Year Founded
-
1998
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
M&A
- Financing Rounds
-
7
EffRx General Information
Description
Operator of a pharmaceutical company focused on the development and commercialization of prescription drugs targeting in particular musculoskeletal and rare pathologies on the European and international markets. The company's product line includes soluble buffered alendronate, a key bisphosphonate class agent used in the treatment of osteoporosis, thereby enabling physicians, payers and patients with better clinical and commercial value propositions.
Contact Information
Website
www.effrx.comCorporate Office
- Wolleraustrasse 41B
- 8807 Freienbach
- Switzerland
Corporate Office
- Wolleraustrasse 41B
- 8807 Freienbach
- Switzerland
EffRx Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
EffRx Comparisons
Industry
Financing
Details
EffRx Competitors (31)
One of EffRx’s 31 competitors is Cipla, a Corporation company based in Mumbai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cipla | Corporation | Mumbai, India | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| Merck & Co. | Corporation | Rahway, NJ | ||||
| Gesynta Pharma | Venture Capital-Backed | Stockholm, Sweden | ||||
| Biocon | Formerly PE-Backed | Bengaluru, India |
EffRx Patents
EffRx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2014322810-A1 | Low-sodium effervescent pharmaceutical formulations | Inactive | 21-Sep-2013 | ||
| CA-2922977-A1 | Low-sodium effervescent pharmaceutical formulations | Inactive | 21-Sep-2013 | ||
| EP-3046549-A1 | Low-sodium effervescent pharmaceutical formulations | Inactive | 21-Sep-2013 | ||
| US-20160220481-A1 | Low-sodium effervescent pharmaceutical formulations | Inactive | 21-Sep-2013 | ||
| WO-2015040460-A1 | Low-sodium effervescent pharmaceutical formulations | Inactive | 21-Sep-2013 | A61K9/0007 |
EffRx Signals
EffRx FAQs
-
When was EffRx founded?
EffRx was founded in 1998.
-
Where is EffRx headquartered?
EffRx is headquartered in Freienbach, Switzerland.
-
What is the size of EffRx?
EffRx has 15 total employees.
-
What industry is EffRx in?
EffRx’s primary industry is Drug Discovery.
-
Is EffRx a private or public company?
EffRx is a Private company.
-
What is EffRx’s current revenue?
The current revenue for EffRx is .
-
How much funding has EffRx raised over time?
EffRx has raised $4.41M.
-
Who are EffRx’s competitors?
Cipla, Novartis, Merck & Co., Gesynta Pharma, and Biocon are some of the 31 competitors of EffRx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process